EU-OPENSCREEN joins forces with other leading life science research infrastructures to fight COVID-19 and future pandemics
EU-OPENSCREEN integrates high-capacity screening platforms throughout Europe. These platforms use specially selected EU-OPENSCREEN compound collections, which are centrally stored and managed at the EU-OPENSCREEN laboratory facility in Berlin-Buch (Germany).
All compound structures and primary screening data will be published in the open-access European Chemical Biology Database (ECBD), where they are made available to a wide scientific audience.
EU-OPENSCREEN collaboratively develops novel molecular tool compounds and early therapeutic candidate molecules together with external users from various disciplines of the life sciences. Access to the EU-OPENSCREEN resources is open to researchers from academia and industry from countries inside and outside of the European Union.